Auranofin, identified by FDA-approved drug library screening, inhibits HBs antigen secretion via lysosomal damage.
Shimoda A, Murai K, Hikita H, Minami S, Miyake T, Kuriki S, Sometani E, Sung J, Shigeno S, Higuchi Y, Maesaka K, Shirai K, Tahata Y, Saito Y, Kodama T, Takahashi T, Suemizu H, Takehara T.
Shimoda A, et al. Among authors: higuchi y.
PLoS One. 2026 Jan 16;21(1):e0340023. doi: 10.1371/journal.pone.0340023. eCollection 2026.
PLoS One. 2026.
PMID: 41544073
Free PMC article.